Active Ingredient Prescribing: What GPs need to know

Dr Charlotte Middleton

expert

Dr Charlotte Middleton

General Practitioner; Chief Medical Officer, Biolae

This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.

Written by Dr Charlotte Middleton BMBS, DipCH, FRACGP, CHIA (Health Informatics)

Dr Charlotte Middleton is Chief Medical Officer for MedicalDirector and a practising GP with 23 years clinical experience. Dr Middleton specialises in integrative medicine and has a keen interest in the role of technology in healthcare. As MedicalDirector’s CMO, Dr Middleton provides clinical oversight of all their products, including their cloud-based practice management software, Helix.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Ted Wu

Dr Ted Wu

Oral GLP1s – What GPs Need to Know

Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Charlotte Middleton

expert

Dr Charlotte Middleton

General Practitioner; Chief Medical Officer, Biolae

Test your knowledge

Recent articles

Latest GP poll

To what extent do you attribute the current political climate to experiences of racial/ethnic discrimination?

A great extent

0%

A moderate extent

0%

Slightly

0%

Not at all

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.